{
    "eid": "2-s2.0-85128336511",
    "title": "Fecal Calprotectin as a Surrogate Marker for Mucosal Healing After Initiating the Therapeutic Anti-Tubercular Trial",
    "cover-date": "2022-03-01",
    "subject-areas": [
        {
            "@_fa": "true",
            "$": "Medicine (miscellaneous)",
            "@code": "2701",
            "@abbrev": "MEDI"
        },
        {
            "@_fa": "true",
            "$": "Radiology, Nuclear Medicine and Imaging",
            "@code": "2741",
            "@abbrev": "MEDI"
        },
        {
            "@_fa": "true",
            "$": "Gastroenterology",
            "@code": "2715",
            "@abbrev": "MEDI"
        }
    ],
    "keywords": [],
    "authors": [
        "Satimai Aniwan"
    ],
    "citedby-count": 0,
    "ref-count": 10,
    "ref-list": [
        "Asian Organization for Crohn's and Colitis and Asia Pacific Association of Gastroenterology practice recommendations for medical management and monitoring of inflammatory bowel disease in Asia",
        "Histopathology and TB-PCR kit analysis in differentiating the diagnosis of intestinal tuberculosis and Crohn's disease",
        "Development and validation of a new algorithm model for differential diagnosis between Crohn's disease and intestinal tuberculosis: a combination of laboratory, imaging and endoscopic characteristics",
        "Meta-analytic Bayesian model for differentiating intestinal tuberculosis from crohn's disease",
        "A meta-analysis of the accuracy of interferon-\u03b3 release assays in differentiating intestinal tuberculosis from Crohn's disease in Asia",
        "Levels of TB-IGRA may help to differentiate between intestinal tuberculosis and Crohn's disease in patients with positive results",
        "Intestinal tuberculosis or Crohn's disease: a review of the diagnostic models designed to differentiate between these two gastrointestinal diseases",
        "Validation of models using basic parameters to differentiate intestinal tuberculosis from Crohn's disease: a multicenter study from Asia",
        "Value of fecal calprotectin measurement during the initial period of therapeutic anti-tubercular trial",
        "Serial measurements of faecal calprotectin may discriminate intestinal tuberculosis and Crohn's disease in patients started on antitubercular therapy"
    ],
    "affiliation": {
        "affiliation-city": "Bangkok",
        "@id": "60002620",
        "affilname": "Faculty of Medicine, Chulalongkorn University",
        "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60002620",
        "affiliation-country": "Thailand"
    },
    "funding": []
}